Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms

被引：0

作者：

Gurban, Petruta ^{[1
,2
]}

Mambet, Cristina ^{[1
,3
,4
]}

Botezatu, Anca ^{[5
]}

Necula, Laura G. ^{[1
]}

Matei, Lilia ^{[1
]}

Neagu, Ana Iulia ^{[1
,6
]}

Pitica, Ioana ^{[1
]}

Ataman, Marius ^{[1
]}

Tatic, Aurelia ^{[1
,3
,7
]}

Bardas, Alexandru ^{[1
,3
,7
]}

Gaman, Mihnea A. ^{[1
,3
,7
]}

Dobrea, Camelia ^{[3
,7
]}

Dragomir, Mihaela ^{[7
]}

Ghimici, Cecilia ^{[8
]}

Angelescu, Silvana ^{[3
,8
]}

Barbu, Doina ^{[8
]}

Stanca, Oana ^{[3
,8
]}

Danila, Marina ^{[8
]}

Berbec, Nicoleta ^{[3
,8
]}

Colita, Andrei ^{[3
,8
]}

Vladareanu, Ana Maria ^{[3
,4
]}

Nedeianu, Saviana ^{[1
]}

Chivu-Economescu, Mihaela ^{[1
]}

Bleotu, Coralia ^{[1
]}

Coriu, Daniel ^{[1
,3
,7
]}

Sepulchre, Elise ^{[9
]}

Anton, Gabriela ^{[5
]}

Diaconu, Carmen C. ^{[1
]}

Constantinescu, Stefan N. ^{[9
,10
,11
,12
]}

机构：

[1] Romanian Acad, Stefan S Nicolau Inst Virol, Cellular & Mol Pathol Dept, Bucharest, Romania

[2] Cytogenom Med Lab, Bucharest, Romania

[3] Carol Davila Univ Med & Pharm, Fac Med, Dept Radiol Oncol & Hematol, Bucharest, Romania

[4] Emergency Univ, Clin Hosp, Hematol Dept, Bucharest, Romania

[5] Romanian Acad, Stefan S Nicolau Inst Virol, Mol Virol Dept, Bucharest, Romania

[6] Carol Davila Univ Med & Pharm, Fac Med, Infect Dis Epidemiol Microbiol Parasitol Virol Dia, Bucharest, Romania

[7] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

[8] Coltea Clin Hosp, Hematol Dept, Bucharest, Romania

[9] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium

[10] Ludwig Inst Canc Res Brussels, SIGN Cell Signalling & Mol Hematol, Brussels, Belgium

[11] WEL Res Inst, Walloon Excellence Life Sci & Biotechnol WELBIO De, Wavre, Belgium

[12] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 01期

关键词：

D O I：

10.1002/ajh.27503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：168 / 171

页数：4

共 50 条

[41] Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms
Abdel-Wahab, Omar
Pardanani, Animesh
Patel, Jay
Lasho, Terra
Heguy, Adriana
Levine, Ross
Tefferi, Ayalew
BLOOD, 2010, 116 (21) : 1266 - 1266
[42] Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease
Yeoh, Zhi-Han
Wei, Andrew
LEUKEMIA & LYMPHOMA, 2023,
[43] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
Abdel-Wahab, O.
Pardanani, A.
Patel, J.
Wadleigh, M.
Lasho, T.
Heguy, A.
Beran, M.
Gilliland, D. G.
Levine, R. L.
Tefferi, A.
LEUKEMIA, 2011, 25 (07) : 1200 - 1202
[44] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
O Abdel-Wahab
A Pardanani
J Patel
M Wadleigh
T Lasho
A Heguy
M Beran
D G Gilliland
R L Levine
A Tefferi
Leukemia, 2011, 25 : 1200 - 1202
[45] The Potential Role of CAL2 and EZH2 Immunohistochemical Stainings as Diagnostic and Prognostic Surrogate Markers in Classical BCR/ABL1-negative Myeloproliferative Neoplasms
Ozogul, Ece
Ozgeyik, Mufide Okay
Ayhan, Arzu Saglam
Malkan, Umit Yavuz
Haznedaroglu, Ibrahim Celalettin
Uner, Aysegul
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2023, 33 (04): : 248 - 257
[46] Diagnostic and therapeutic pitfalls of the BCR-ABL1 negative myeloproliferative neoplasms (MPNs) associated thromboembolism
Schilling, K.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 132 - 132
[47] Potential Applications of Liquid Biopsy in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Systematic Review
Gaman, Mihnea-Alexandru
Cozma, Matei-Alexandru
Dobrica, Elena-Codruta
Cretoiu, Sanda Maria
Gaman, Amelia Maria
Diaconu, Camelia Cristina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S364 - S365
[48] A Review on the Role of Molecular Genetics in the Diagnostic Workup of BCR::ABL1 -Negative Myeloproliferative Neoplasms
Maddali, Madhavi
Arunachalam, Arun Kumar
Kapadia, Alpesh Kumar BipinBhai
Kulkarni, Uday Prakash
Balasubramanian, Poonkuzhali
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (06) : 578 - 584
[49] Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms
Aswad, Mohamed Hussam
Kissova, Jarmila
Ovesna, Petra
Penka, Miroslav
NEOPLASMA, 2021, 68 (06) : 1341 - 1350
[50] Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms
Mughal, Tariq I.
Gotlib, Jason
Mesa, Ruben
Koschmieder, Steffen
Khoury, H. Jean
Cortes, Jorge E.
Barbui, Tiziano
Hehlmann, Rudiger
Mauro, Michael
Saussele, Susanne
Radich, Jerald P.
Van Etten, Richard A.
Saglio, Giuseppe
Verstovek, Srdnan
Gale, Robert Peter
Abdel-Wahab, Omar
LEUKEMIA RESEARCH, 2018, 67 : 67 - 74

← 1 2 3 4 5 →